A Cdk7-Cdk4 T-Loop Phosphorylation Cascade Promotes G1 Progression

Molecular Cell

Volumn 50, Issue 2, 2013, Pages 250-260

  Schachter, MiriamMerzel ^a   Merrick, KarlA ^a,b,f   Larochelle, Stéphane ^a   Hirschi, Alexander ^c   Zhang, Chao ^d   Shokat, KevanM ^e   Rubin, SethM ^c   Fisher, RobertP ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 7; MITOGENIC AGENT;

ANIMAL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN HCT116; CELL SYNCHRONIZATION; CHEMICAL GENETICS; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTACT INHIBITION; ENZYME ACTIVATION; EUKARYOTIC CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; INTRACELLULAR SPACE; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; CELL PROLIFERATION; CYCLIN D; CYCLIN H; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; EPISTASIS, GENETIC; G1 PHASE; HCT116 CELLS; HUMANS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETINOBLASTOMA PROTEIN; S PHASE;

EUKARYOTA; METAZOA;

EID: 84876860706     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.04.003     Document Type: Article

References (50)

1. Adamczewski J.P., Rossignol M., Tassan J.-P., Nigg E.A., Moncollin V., Egly J.-M. MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH. EMBO J. 1996, 15:1877-1884.
2. Aprelikova O., Xiong Y., Liu E.T. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J.Biol. Chem. 1995, 270:18195-18197.
3. Bockstaele L., Kooken H., Libert F., Paternot S., Dumont J.E., de Launoit Y., Roger P.P., Coulonval K. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors". Mol. Cell. Biol. 2006, 26:5070-5085.
4. Bockstaele L., Bisteau X., Paternot S., Roger P.P. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation. Mol. Cell. Biol. 2009, 29:4188-4200.
5. Burke J.R., Deshong A.J., Pelton J.G., Rubin S.M. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J.Biol. Chem. 2010, 285:16286-16293.
6. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., Sherr C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 1999, 18:1571-1583.
7. Cheng A., Kaldis P., Solomon M.J. Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2C alpha and beta 2 isoforms. J.Biol. Chem. 2000, 275:34744-34749.
8. Chu I., Sun J., Arnaout A., Kahn H., Hanna W., Narod S., Sun P., Tan C.K., Hengst L., Slingerland J. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007, 128:281-294.
9. Day P.J., Cleasby A., Tickle I.J., O'Reilly M., Coyle J.E., Holding F.P., McMenamin R.L., Yon J., Chopra R., Lengauer C., Jhoti H. Crystal structure of human CDK4 in complex with a D-type cyclin. Proc. Natl. Acad. Sci. USA 2009, 106:4166-4170.
10. Donner A.J., Ebmeier C.C., Taatjes D.J., Espinosa J.M. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat. Struct. Mol. Biol. 2010, 17:194-201.
11. Fisher R.P. Secrets of a double agent: CDK7 in cell-cycle control and transcription. J.Cell Sci. 2005, 118:5171-5180.
12. Fry D.W., Harvey P.J., Keller P.R., Elliott W.L., Meade M., Trachet E., Albassam M., Zheng X., Leopold W.R., Pryer N.K., Toogood P.L. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol. Cancer Ther. 2004, 3:1427-1438.
13. Ganuza M., Sáiz-Ladera C., Cañamero M., Gómez G., Schneider R., Blasco M.A., Pisano D., Paramio J.M., Santamaría D., Barbacid M. Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion. EMBO J. 2012, 31:2498-2510.
14. Garrett S., Barton W.A., Knights R., Jin P., Morgan D.O., Fisher R.P. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop. Mol. Cell. Biol. 2001, 21:88-99.
15. Grimmler M., Wang Y., Mund T., Cilensek Z., Keidel E.M., Waddell M.B., Jäkel H., Kullmann M., Kriwacki R.W., Hengst L. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 2007, 128:269-280.
16. Harper J.W., Elledge S.J. The role of Cdk7 in CAK function, a retro-retrospective. Genes Dev. 1998, 12:285-289.
17. James M.K., Ray A., Leznova D., Blain S.W. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity. Mol. Cell. Biol. 2008, 28:498-510.
18. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massagué J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 1995, 376:313-320.
19. Kip1) of cyclin-dependent kinase 4 activation. Cell 1994, 79:487-496.
20. Kueng W., Silber E., Eppenberger U. Quantification of cells cultured on 96-well plates. Anal. Biochem. 1989, 182:16-19.
21. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 1997, 11:847-862.
22. Larochelle S., Pandur J., Fisher R.P., Salz H.K., Suter B. Cdk7 is essential for mitosis and for invivo Cdk-activating kinase activity. Genes Dev. 1998, 12:370-381.
23. Larochelle S., Chen J., Knights R., Pandur J., Morcillo P., Erdjument-Bromage H., Tempst P., Suter B., Fisher R.P. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex invivo and regulates its CTD kinase activity. EMBO J. 2001, 20:3749-3759.
24. Larochelle S., Batliner J., Gamble M.J., Barboza N.M., Kraybill B.C., Blethrow J.D., Shokat K.M., Fisher R.P. Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics. Nat. Struct. Mol. Biol. 2006, 13:55-62.
25. Larochelle S., Merrick K.A., Terret M.E., Wohlbold L., Barboza N.M., Zhang C., Shokat K.M., Jallepalli P.V., Fisher R.P. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol. Cell 2007, 25:839-850.
26. Larochelle S., Amat R., Glover-Cutter K., Sansó M., Zhang C., Allen J.J., Shokat K.M., Bentley D.L., Fisher R.P. Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat. Struct. Mol. Biol. 2012, 19:1108-1115.
27. Larrea M.D., Liang J., Da Silva T., Hong F., Shao S.H., Han K., Dumont D., Slingerland J.M. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4. Mol. Cell. Biol. 2008, 28:6462-6472.
28. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 1998, 18:753-761.
29. Matsuoka M., Kato J.Y., Fisher R.P., Morgan D.O., Sherr C.J. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 1994, 14:7265-7275.
30. Matsushime H., Roussel M.F., Ashmun R.A., Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991, 65:701-713.
31. PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992, 71:323-334.
32. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.-Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 1994, 14:2066-2076.
33. Merrick K.A., Larochelle S., Zhang C., Allen J.J., Shokat K.M., Fisher R.P. Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells. Mol. Cell 2008, 32:662-672.
34. Merrick K.A., Wohlbold L., Zhang C., Allen J.J., Horiuchi D., Huskey N.E., Goga A., Shokat K.M., Fisher R.P. Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation. Mol. Cell 2011, 42:624-636.
35. Meyerson M., Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 1994, 14:2077-2086.
36. Morgan D.O. The Cell Cycle: Principles of Control 2007, New Science Press Ltd, London.
37. Nevins J.R. Cell cycle targets of the DNA tumor viruses. Curr. Opin. Genet. Dev. 1994, 4:130-134.
38. Pardee A.B. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 1974, 71:1286-1290.
39. 160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science 1995, 270:90-93.
40. Ray A., James M.K., Larochelle S., Fisher R.P., Blain S.W. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes. Mol. Cell. Biol. 2009, 29:986-999.
41. Rocha A.S., Paternot S., Coulonval K., Dumont J.E., Soares P., Roger P.P. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation. Mol. Biol. Cell 2008, 19:4814-4825.
42. Rubin S.M., Gall A.L., Zheng N., Pavletich N.P. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 2005, 123:1093-1106.
43. Russo A.A., Jeffrey P.D., Pavletich N.P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 1996, 3:696-700.
44. Sherr C.J. Cancer cell cycles. Science 1996, 274:1672-1677.
45. Takaki T., Echalier A., Brown N.R., Hunt T., Endicott J.A., Noble M.E. The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc. Natl. Acad. Sci. USA 2009, 106:4171-4176.
46. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
47. Wohlbold L., Larochelle S., Liao J.C., Livshits G., Singer J., Shokat K.M., Fisher R.P. The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity. Cell Cycle 2006, 5:546-554.
48. Yankulov K.Y., Bentley D.L. Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 1997, 16:1638-1646.
49. Yao G., Lee T.J., Mori S., Nevins J.R., You L. A bistable Rb-E2F switch underlies the restriction point. Nat. Cell Biol. 2008, 10:476-482.
50. Zarkowska T., Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J.Biol. Chem. 1997, 272:12738-12746.